It seems they (AIFA) have titled it this way

http://www.agenziafarmaco.gov.it/allegati/ppri_italy_final.p...
Italy uses a positive list of all reimbursable pharmaceuticals, named the National Pharmaceutical
Formulary (PFN). The list is managed at central level by the Italian Medicines Agency (AIFA).
The reimbursement positive list is updated annually, or every six months if public pharmaceutical
expenditure (PE) exceeds the 13% ceiling.
Methodological revision of the reimbursement list has been defined by specific laws. The main
renewal was established by Law No. 178/200254 which provided the restructuring of the list based on cost-effectiveness criteria, in order to contain public pharmaceutical expenditure (PE)

54 Law No.178/2002 Legge 8 agosto 2002, No. 178 - conversione in legge del Decreto-Legge 8 Luglio 2002, No.
138 "Interventi urgenti in materia tributaria, di privatizzazioni, di contenimento della spesa farmaceutica e per
il sostegno dell'economia anche nelle aree svantaggiate" GU No. 187 del 10-8-2002
PPRI - Pharma Profile
Italy

planned in financial laws and according to the State-Regions-Trento and Bolzano Autonomous
Provinces Agreements of 8 August 2001.55
The criteria for inclusion in the lists are the same as those described in the eligibility criteria for reimbursement (cf. 4.2.1).
A copy of the National Pharmaceutical Formulary (PFN) is sent free of charge to every doctor
and pharmacist in the country. It is also available on the Italian Medicines Agency (AIFA) web
site.


--------------------------------------------------
Note added at 6 giorni (2012-11-19 12:39:14 GMT) Post-grading
--------------------------------------------------



Grazie mille a te Karen.